Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions
NCT04975373Unknown
- Sponsor
- Barzilai Medical Center
- Start
- Jun 2021
- Primary completion
- Jul 2022
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of hyaluronic acid in Intrauterine Adhesions (IUA) (2 arms), sponsored by Barzilai Medical Center. Primary endpoint: Presence of any intrauterine adhesions. Status: unknown.
02
Drugs
hyaluronic acid
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on NCT04975373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04975373.